Microbial Dysbiosis in Colorectal Cancer Patients
Author Information
Author(s): Sobhani Iradj, Tap Julien, Roudot-Thoraval Françoise, Roperch Jean P., Letulle Sophie, Langella Philippe, Corthier Gérard, Van Nhieu Jeanne Tran, Furet Jean P.
Primary Institution: Université Paris-Est Créteil, France
Hypothesis
The study aims to analyze the microbiota of normal and colon cancer patients to establish cancer-related dysbiosis.
Conclusion
The study demonstrates a composition change in the microbiota of colon cancer patients, which may impact mucosal immune response.
Supporting Evidence
- 80% of all sequences could be assigned to a total of 819 taxa.
- IL17 immunoreactive cells were significantly expressed more in the normal mucosa of cancer patients.
- Bacteroides/Prevotella group density was higher in cancer patients compared to normal individuals.
Takeaway
This study found that the bacteria in the intestines of colon cancer patients are different from those in healthy people, which might affect their immune system.
Methodology
Stool bacterial DNA was extracted from 179 patients and analyzed using pyrosequencing and qPCR.
Potential Biases
The selection of control subjects may introduce bias as they were not healthy volunteers but individuals with normal colonoscopy.
Limitations
The study may not account for all potential confounding factors affecting microbiota composition.
Participant Demographics
Patients included 60 with colorectal cancer and 119 with normal colonoscopy, matched for gender and age.
Statistical Information
P-Value
0.009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website